Vimarsana
Biggest News Aggregation in the World

Page 5 - Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Details Today - Breaking & Trending Today

Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™ - Vimarsana News

Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™

SOUTH SAN FRANCISCO, Calif., Feb. 01, 2024 -- Denali Therapeutics Inc. , a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier ...

Hillman Sets Fourth Quarter 2023 Earnings Release and Results Presentation Date - Vimarsana News

Hillman Sets Fourth Quarter 2023 Earnings Release and Results Presentation Date

CINCINNATI, Feb. 01, 2024 -- Hillman Solutions Corp. , a leading provider of hardware products and merchandising solutions, plans to host a conference call to discuss its results for the thirteen...

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference - Molecular Partners (NASDAQ:MOLN) - Vimarsana News

Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference - Molecular Partners (NASDAQ:MOLN)

Tetra-specific T-cell engager MP0533 for patients with r/r AML and AML/MDS on track to deliver expanded clinical phase 1/2a data in H1 2024Progress of Radio-DARPin Therapy (RDT) platform: Improved tumor to kidney uptake

Molecular Partners Provides Updates at 42nd Annual J.P. - Vimarsana News

Molecular Partners Provides Updates at 42nd Annual J.P.

Tetra-specific T-cell engager MP0533 for patients with r/r AML and AML/MDS on track to deliver expanded clinical phase 1/2a data in H1 2024Progress of...

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

VANCOUVER, British Columbia, Jan. 03, 2024 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 42nd Annual J.P....